Evidence map›Paper›PMID 38927793›Full record

ArticleBioengineering (Basel, Switzerland)2024

Explainable Precision Medicine in Breast MRI: A Combined Radiomics and Deep Learning Approach for the Classification of Contrast Agent Uptake.

Sylwia Nowakowska, Karol Borkowski, Carlotta Ruppert, Patryk Hejduk, Alexander Ciritsis, Anna Landsmann, Magda Marcon, Nicole Berger, Andreas Boss, Cristina Rossi

Abstract read
In one paragraph

Article in Bioengineering (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Sylwia NowakowskaDiagnostic and Interventional Radiology, University Hospital Zürich, University Zürich, Rämistrasse 100, 8091 Zürich, Switzerland.
Karol Borkowskib-rayZ AG, Wagistrasse 21, 8952 Schlieren, Switzerland.
Carlotta RuppertDiagnostic and Interventional Radiology, University Hospital Zürich, University Zürich, Rämistrasse 100, 8091 Zürich, Switzerland.ORCID 0000-0003-4360-822X
Patryk HejdukDiagnostic and Interventional Radiology, University Hospital Zürich, University Zürich, Rämistrasse 100, 8091 Zürich, Switzerland.
Alexander CiritsisDiagnostic and Interventional Radiology, University Hospital Zürich, University Zürich, Rämistrasse 100, 8091 Zürich, Switzerland.
Anna LandsmannDiagnostic and Interventional Radiology, University Hospital Zürich, University Zürich, Rämistrasse 100, 8091 Zürich, Switzerland.ORCID 0000-0001-8240-5797
Magda MarconDiagnostic and Interventional Radiology, University Hospital Zürich, University Zürich, Rämistrasse 100, 8091 Zürich, Switzerland.
Nicole BergerDiagnostic and Interventional Radiology, University Hospital Zürich, University Zürich, Rämistrasse 100, 8091 Zürich, Switzerland.
Andreas BossDiagnostic and Interventional Radiology, University Hospital Zürich, University Zürich, Rämistrasse 100, 8091 Zürich, Switzerland.
Cristina RossiDiagnostic and Interventional Radiology, University Hospital Zürich, University Zürich, Rämistrasse 100, 8091 Zürich, Switzerland.

Funding

University of Zurich CRPP AI in oncological imaging
6 · The paper itself

Abstract

In DCE-MRI, the degree of contrast uptake in normal fibroglandular tissue, i.e., background parenchymal enhancement (BPE), is a crucial biomarker linked to breast cancer risk and treatment outcome. In accordance with the Breast Imaging Reporting & Data System (BI-RADS), it should be visually classified into four classes. The susceptibility of such an assessment to inter-reader variability highlights the urgent need for a standardized classification algorithm. In this retrospective study, the first post-contrast subtraction images for 27 healthy female subjects were included. The BPE was classified slice-wise by two expert radiologists. The extraction of radiomic features from segmented BPE was followed by dataset splitting and dimensionality reduction. The latent representations were then utilized as inputs to a deep neural network classifying BPE into BI-RADS classes. The network's predictions were elucidated at the radiomic feature level with Shapley values. The deep neural network achieved a BPE classification accuracy of 84 ± 2% (

Indexed as

background parenchymal enhancementBI-RADS-compliant BPE classificationbreast cancer riskbreast dynamic contrast-enhanced MRIdeep neural networksexplainable AIradiomicsShapley values

Identifiers

PMID38927793
PMCPMC11200390

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.